-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
(Health Times reporter Dong Rui) On March 29, Shanghai Roche Pharmaceutical Co.
(Health Times reporter Dong Rui)
Xeloda is a basic drug in the treatment of colorectal cancer, gastric cancer and breast cancer, and has a synergistic effect with a variety of anti-tumor drugs.
Tarceva is the first-generation molecular targeted drug for the treatment of lung cancer produced by Roche Pharmaceuticals.
In this regard, Fu Gang, Chairman of Baiyang Pharmaceutical Group, said: “Roche Pharmaceuticals is a leading biopharmaceutical company in the world.